Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for Postoperative Cognition in Elderly Orthopedic Patients
NCT04017403Unknown
- Sponsor
- Renji Hospital
- Start
- Dec 2019
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Randomised, double-blind trial of Bifidobacterium tetravaccine in Post-operative cognitive dysfunction (POCD) and postoperative delirium (POD) (2 arms), sponsored by Renji Hospital. Primary endpoint: Incidence of Postoperative Cognitive Dysfunction 7 days after surgery. Status: unknown.
02
Drugs
Bifidobacterium tetravaccine
03
Conditions
Post-operative cognitive dysfunction (POCD)postoperative delirium (POD)
Beyond the preview
Go deeper on NCT04017403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04017403.